Stressgen (VSE: SSB) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Stressgen (VSE: SSB)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: james paterson who wrote (82)	1/30/1999 1:40:00 PM
From: Heat Shock	Read Replies (1) of 236

To all: Biotechnology Industry Organization to Host Unique Investor Conference Highlighting Biotechnology's Prospects for Improving Health Care I see StressGen CEO Richard Glickman is in a CEO round table on Creative Financing where "Particular emphasis is placed on risk sharing and minimization of dilution." Sounds OK to me. Also, StressGen is listed as participating in an investor session on "Vaccines and Women's Health Issues" StressGen is in a joint venture with Genzyme Molecular Oncology, which is listed as being in an investor session "Solid Tissue Tumors: New and Emerging Anti-Cancer Therapies". Interestingly, StressGen competitor Antigenics, LLC is in an investor session "Oncology: The Strategic / Competitive Landscape". Here is the conference site: bio.org THE BIO CEO & INVESTOR CONFERENCE February 24-26, 1999 New York Palace Hotel • New York, NY Anybody in the big apple on these dates? Heat Shock

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next